Rio Tinto Alcan donates $1 million to the Montreal Neurological Institute



    MONTREAL, Jan. 16 /CNW Telbec/ - Rio Tinto Alcan announced today a
$1 million donation to the Thinking Ahead campaign of the Montreal
Neurological Institute and Hospital (MNI), one of the world's premier centres
for neuroscience research and clinical care. This donation will help build,
equip and start up the Rio Tinto Alcan Laboratory of NeuroEngineering.
    "Rio Tinto Alcan believes in supporting innovative institutions and
organizations in the communities where we are present," said Dick Evans, Chief
Executive, Rio Tinto Alcan. "Good health and strong healthcare facilities are
key to a community's success and growth. Supporting the MNI's innovative
NeuroEngineering Program is another way that we can play a role in improving
the quality of life of people in Quebec and around the world. Advancement in
this area could lead to significant scientific and medical breakthroughs that
benefit populations everywhere."
    The Thinking Ahead campaign is a five-year, $40-million initiative to
expand the MNI's facilities, attract top talent and equip them with the tools
they need to create a world of change in the treatment of brain disease.
    "We are very proud that Rio Tinto Alcan has chosen to invest in the MNI's
ongoing development," said David R. Colman, Director of the MNI. "Rio Tinto
Alcan's support of the NeuroEngineering program gives us the opportunity to
expand our research into new directions that we can't even imagine now -
exploring and bringing together new disciplines and technologies that we hope
will improve the quality of life for those debilitated by neurological injury
or disease."
    Rio Tinto Alcan has been a major contributor to Quebec's social fabric
and well-being since establishing its presence in the province more than
100 years ago. The Group supports more than 200 organizations in Quebec,
including the Festival International de Jazz de Montréal, Sainte-Justine
Hospital and its recent contribution to the creation of a new planetarium in
Montreal.

    About Rio Tinto

    Rio Tinto is a leading international mining group headquartered in the
UK, combining Rio Tinto plc, a London listed company, and Rio Tinto Limited,
which is listed on the Australian Securities Exchange.
    Rio Tinto's business is finding, mining, and processing mineral
resources. Major products are aluminium, copper, diamonds, energy (coal and
uranium), gold, industrial minerals (borax, titanium dioxide, salt, talc) and
iron ore. Activities span the world but are strongly represented in Australia
and North America with significant businesses in South America, Asia, Europe
and southern Africa.

    About the MNI

    The Montreal Neurological Institute is a McGill University research and
teaching institute, dedicated to the study of the nervous system and
neurological diseases. Founded in 1934 by the renowned Dr. Wilder Penfield,
the MNI is one of the world's largest institutes of its kind. MNI researchers
are world leaders in cellular and molecular neuroscience, brain imaging,
cognitive neuroscience and the study and treatment of epilepsy, multiple
sclerosis and neuromuscular disorders. For more information, please visit:
www.mni.mcgill.ca.




For further information:

For further information: Rio Tinto Alcan Media Relations, Montreal:
Michelle Adams, (514) 848-8151, michelle.adams@alcan.com; Montreal
Neurological Institute: Sandra McPherson, PhD, (514) 398-1902,
sandra.mcpherson@mcgill.ca; www.riotinto.com/riotintoalcan

Organization Profile

Rio Tinto Alcan

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890